Effects of allopurinol pretreatment on the risk of contrast-induced acute kidney injury in patients undergoing percutaneous coronary intervention: A meta-analysis of randomized controlled trials  .

CONCLUSION: Pretreatment with allopurinol reduces the incidence of CI-AKI in patients undergoing contrast exposure in PCI. The benefits of allopurinol on CI-AKI may be more remarkable in high-risk patients. . PMID: 31661061 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31661061?dopt=Abstract

Source: Clinical Nephrology - October 28, 2019 Category: Urology & Nephrology Authors: Xin W, Lin Z, Zhang T, Jia S Tags: Clin Nephrol Source Type: research

Effects of allopurinol pretreatment on the risk of contrast-induced acute kidney injury in patients undergoing percutaneous coronary intervention: A meta-analysis of randomized controlled trials .

Effects of allopurinol pretreatment on the risk of contrast-induced acute kidney injury in patients undergoing percutaneous coronary intervention: A meta-analysis of randomized controlled trials  .